| Universus Physical Therapy Pllc | |
|
221 E Main St, Huntington, NY 11743-2924 | |
| (631) 533-2888 | |
| (631) 683-5584 |
| Full Name | Universus Physical Therapy Pllc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 221 E Main St, Huntington, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124394457 | NPI | - | NPPES |
| 028157 | Other | NY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 028157 (New York) | Primary |
| Provider Name | Shaden G Ryglewicz |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1306948450 PECOS PAC ID: 4385829415 Enrollment ID: I20110504000654 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Tiffany Combs |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275878373 PECOS PAC ID: 8820232150 Enrollment ID: I20130926000223 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Jennifer Helft |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1174042733 PECOS PAC ID: 6305105701 Enrollment ID: I20180110001452 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Christopher Dinh |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1396348272 PECOS PAC ID: 1557773140 Enrollment ID: I20201228000441 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Nathaniel Mark Mailloux |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1013517788 PECOS PAC ID: 7810300571 Enrollment ID: I20210119002682 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Carly Loewenstein |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1619360708 PECOS PAC ID: 3870904303 Enrollment ID: I20210616003038 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Daniela Escudero |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1861069528 PECOS PAC ID: 0941602163 Enrollment ID: I20210712000698 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | John Fleitman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1326706110 PECOS PAC ID: 0648660787 Enrollment ID: I20211206000692 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Provider Name | Zinnia Dodson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053189829 PECOS PAC ID: 6406209444 Enrollment ID: I20240126000198 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Universus Physical Therapy Pllc 221 E Main St, Huntington, NY 11743-2924 Ph: (631) 533-2888 | Universus Physical Therapy Pllc 221 E Main St, Huntington, NY 11743-2924 Ph: (631) 533-2888 |
News Archive
Research by a team of Vanderbilt University Medical Center scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer's pathology first begins.
Cohera Medical, Inc., a rapidly growing medical device company, announced today that it has received CE Mark approval for its lead product, TissuGlu® Surgical Adhesive. CE Mark approval allows TissuGlu to be sold in the European Union.
Researchers at the Georgia Institute of Technology have designed a multiple-compartment gel capsule that could be used to simultaneously deliver drugs of different types. The researchers used a simple "one-pot" method to prepare the hydrogel capsules, which measure less than one micron.
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
A study of deployed and non-deployed active duty, female Air Force personnel found that both rates of exposure to wartime experiences and reports of post-traumatic stress disorder (PTSD) increased between 2008 and 2013. Rates of post-deployment PTSD were highest among women who reported wartime experiences during deployment.
› Verified 5 days ago
John W Titcomb, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1206 E Jericho Tpke Unit A, Huntington, NY 11743 Phone: 631-549-0749 Fax: 631-549-1562 | |
Mr. Ward Tucker Iii, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 141 E Main St, Huntington, NY 11743 Phone: 631-421-9111 | |
Melanie Carminati, Physical Therapist Medicare: Medicare Enrolled Practice Location: 13 South Ln, Huntington, NY 11743 Phone: 631-219-9194 | |
Zinnia Dodson, Physical Therapist Medicare: Medicare Enrolled Practice Location: 221 E Main St, Huntington, NY 11743 Phone: 631-533-2888 | |
Mrs. Stephanie Foley, MS PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 467 New York Ave, Huntington, NY 11743 Phone: 631-424-1100 Fax: 631-424-1105 | |
Norbert Jack Ryglewicz, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 232 E Main St, Huntington, NY 11743 Phone: 516-639-1819 | |
Maria Mills, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 709 W Jericho Tpke, Huntington, NY 11743 Phone: 631-549-1280 Fax: 631-549-1005 |